Table 1 Patient characteristics
From: Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation
Number(n) | 7 |
Sex(male)(n) | 7 |
Age(years) | 46.71 ± 12.31 |
Body weight(kg) | 58.85 ± 9.35 |
Indication for cardiac transplantation(n) | Â |
   Coronary artery disease | 1 |
   Dilated cardiomyopathy | 5 |
   Restrictive cardiomyopathy | 1 |
Perioperative parameters | Â |
   Cold ischemia time of donor heart(min) | 284.29 ± 66.92 |
   Bypass time(min) | 189.86 ± 73.28 |
   Aortic clamping time(min) | 70.71 ± 9.14 |
   CVP(mmHg) | 5.92 ± 3.08 |
   PCWP(mmHg) | 9.16 ± 2.59 |
   CO(L/min) | 4.76 ± 1.00 |
   Inotrope Score(micrograms /kg/min) | 7.72 ± 3.48 |
   Ventilation time(min) | 38.43 ± 24.64 |
   Length of ICU stay(days) | 3.49 ± 2.46 |
   Use of ECMO after transplantation(n) | 2 |
Postoperative Echocardiography | Â |
   Left atrium diameter(mm) | 41.29 ± 7.76 |
   Left ventricular ejection fraction (%) | 67.71 ± 7.27 |
   Left ventricular end diastolic dimension (mm) | 43.57 ± 4.47 |
   Interventricular septum(mm) | 9.43 ± 1.40 |
   Right ventricular diameter(mm) | 21.57 ± 5.88 |
Immunosuppressive therapy(n) | Â |
   Cyclosporine | 6 |
   Tacrolimus | 1 |
   Mycophenolate mofetil | 7 |
   Azathioprine | 1 |
   Sirolimus | 0 |
   Prednisone | 7 |